Cytek Biosciences Ratios (2020-2025) | CTKB

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 43.22%62.23%63.52%59.68%64.93%61.89%60.77%57.54%61.16%66.36%60.77%56.72%56.67%56.62%56.75%51.30%54.56%56.32%58.55%48.62%52.34%52.69%
EBT Margin 1.00%27.48%26.13%0.63%10.74%6.04%1.14%-9.42%-3.49%4.57%8.51%-24.37%-13.27%-8.72%7.06%-20.05%-15.41%0.30%17.96%-27.18%-14.86%-14.86%
EBIT Margin -1.14%26.74%25.72%4.66%12.53%8.43%3.39%-6.72%-2.22%3.36%0.17%-32.79%-18.37%-13.38%-0.24%-23.93%-18.29%-8.25%5.20%-36.12%-23.30%-17.58%
EBITDA Margin 42.29%26.74%25.72%4.66%9.67%8.43%3.39%-6.72%-2.22%2.14%7.35%-18.06%-11.19%-13.08%9.97%-14.37%-19.47%2.40%16.63%-29.01%-10.99%-8.83%
Operating Margin -1.14%26.74%25.72%4.66%12.53%8.43%3.39%-6.72%-2.22%3.36%0.17%-32.79%-18.37%-13.38%-0.24%-23.93%-18.29%-8.25%5.20%-36.12%-23.30%-17.58%
Net Margin 9.93%5.76%1.88%0.42%1.01%-5.76%-1.49%4.12%7.30%-18.35%-8.83%-13.45%9.45%-13.75%-22.38%1.83%16.78%-27.50%-12.24%-10.48%
FCF Margin 6.84%37.36%5.88%-16.99%-0.43%10.68%-6.45%-26.81%-21.28%-0.70%6.34%-8.38%-11.60%13.76%7.56%11.05%23.71%1.92%-2.35%-3.22%-8.71%
Efficiency
Inventory Average 27.08M29.84M35.08M41.66M47.36M48.76M58.83M67.62M66.30M63.88M57.81M52.41M48.44M45.35M44.62M47.42M50.57M
Assets Average 342.30M458.81M474.59M489.35M496.06M509.39M522.03M524.81M522.24M506.94M493.26M487.90M487.48M495.36M491.05M487.96M494.12M
Equity Average 196.10M404.29M406.41M409.29M413.82M421.03M424.50M423.82M419.85M404.29M392.84M390.87M387.29M390.60M387.68M378.59M378.06M
Invested Capital -16.03M-10.98M403.19M405.38M407.44M411.13M416.51M427.82M425.59M426.06M417.26M394.71M394.09M390.45M386.70M396.79M380.54M378.35M379.23M
Asset Utilization Ratio 0.350.280.290.300.310.320.320.330.350.380.410.410.410.400.400.400.40
Leverage & Solvency
Interest Coverage Ratio -218.000.00M23.873.028.806.572.68-3.99-1.382.100.12-18.07-22.32-10.79-0.35-24.34-63.63-35.70-0.50-51.46-25.66-18.61
Equity Ratio -0.07-0.050.890.870.840.830.830.820.810.810.800.790.800.800.780.790.790.770.76
Times Interest Earned -218.000.00M23.873.028.806.572.68-3.99-1.382.100.12-18.07-22.32-10.79-0.35-24.34-63.63-35.70-0.50-51.46-25.66-18.61
Valuation
Enterprise Value -166.12M-159.85M-376.80M-364.62M-362.51M-349.90M-341.52M-299.50M-183.61M-229.09M-163.63M-167.63M-169.19M-177.92M-162.30M-98.75M-95.30M-75.47M-93.28M
Return Ratios
Return on Sales 0.42%0.26%0.18%0.00%0.09%0.04%-0.03%-0.06%-0.02%0.04%0.08%-0.18%-0.09%-0.14%0.09%-0.14%-0.22%0.02%0.17%-0.28%-0.12%-0.10%
Return on Capital Employed 0.05%0.02%0.01%0.00%0.00%0.00%-0.02%-0.04%-0.06%-0.06%-0.06%-0.06%-0.06%-0.05%-0.06%-0.06%-0.08%
Return on Invested Capital 0.06%0.01%0.00%0.00%0.00%-0.01%-0.01%-0.03%-0.06%-0.05%-0.05%-0.07%-0.05%-0.06%-0.09%-0.06%-0.07%
Return on Assets 0.03%0.01%0.00%-0.01%0.00%0.00%0.00%-0.01%-0.03%-0.02%-0.02%-0.04%-0.02%-0.01%-0.02%-0.01%-0.03%
Return on Equity 0.05%0.01%0.00%-0.01%-0.01%0.01%-0.01%-0.01%-0.03%-0.03%-0.03%-0.05%-0.03%-0.02%-0.03%-0.02%-0.03%